Bristol-Myers Squibb has agreed to acquire Turning Point Therapeutics for $4.1bn in the latest in a series of bolt-on acquisitions by pharmaceutical companies looking to bolster their drug pipelines. The … Read More
State-held shares are back on the agenda. Popular during Europe’s wave of privatisation in the 1970s and 80s, so called golden shares — spezialaktie in Germany — allowed governments to … Read More
Manmohan Singh is a senior economist at the IMF. The views below are his own, rather than that of the IMF or its executive board. Every year around April I … Read More
Sun’s out, wallets out. Summer travel season is fast approaching and it will be a busy one. After two years of pandemic-related restrictions that scythed non-essential travel, millions are expected … Read More
Japan has passed a landmark law clarifying the legal status of stablecoins, surging ahead in an international race to construct safety nets around the tokens whose peg to mainstream currencies … Read More
Bukalapak is racing to bring Indonesia’s 3.5mn small roadside kiosks online as the ecommerce group attempts to capitalise on its head start in the next battleground for south-east Asia’s technology … Read More
In April this year, 24,000 people were left waiting over 12 hours in England’s emergency departments, the highest this figure has ever been. That same month, roughly 30,000 people who … Read More
Leading pharmaceutical companies are lining up to use a pioneering cancer test developed by UK start-up Angle after it received a first-of-its-kind US regulatory clearance. Angle’s liquid biopsy test captures … Read More
Chief executives have many responsibilities, but one of the most valuable is persuading investors and others that their companies are performing well financially and doing good for the world. If … Read More
The great resignation is not limited to the rank and file. A record number of chief executives are expected to go this year. But some departures come as a surprise … Read More
